In addition, the ability of humanized bevacizumab to detect VEGF in the heart, lung, kidney, and brain could be important predictors of VEGF signaling inhibitor toxicities such as proteinuria, pulmonary hemorrhage, and cardiotoxicity [48], [49]. This evidence concerns the gene VEGFA and Pulmonary hemorrhage.